The invention relates to the use of the sequence encoding the carboxyl-terminal end domain of the heavy chain ofthe tetanus toxin as a drug, preferably in the treatment of amyotrophiclateral sclerosis (ALS), as well as the polypeptide encoded bysaid sequence for the treatment of the aforementioned disease.